# OnCo record scalp-cooling (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/scalp-cooling/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "scalp-cooling" ;
  schema:name "Scalp cooling (cold caps: DigniCap, Paxman)"@en ;
  schema:alternateName "Cold cap"@en, "Scalp hypothermia"@en, "DigniCap"@en, "Paxman Scalp Cooling System"@en ;
  schema:description "A tightly fitted cap chilled to a few degrees above freezing, worn before, during and after each chemotherapy infusion, narrows the blood vessels of the scalp so less drug reaches the hair roots. In a randomised trial about half of women on taxane-based chemotherapy kept most of their hair, compared with none who went without."@en ;
  schema:url <https://onco.cc/technologies/scalp-cooling/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Scalp_cooling> ;
  schema:citation <https://doi.org/10.1001/jama.2016.20939>, <https://doi.org/10.1001/jama.2016.21038>, <https://doi.org/10.1007/s10549-017-4185-9>, <https://paxmanscalpcooling.com/>, <https://www.dignicap.com/>, <https://www.macmillan.org.uk/cancer-information-and-support/impacts-of-cancer/hair-loss>, <https://doi.org/10.1001/jama.2016.20939>, <https://doi.org/10.1001/jama.2016.21038>, <https://www.macmillan.org.uk/cancer-information-and-support/impacts-of-cancer/hair-loss>, <https://doi.org/10.1002/onco.13690> ;
  onco:status "established" ;
  onco:tag "complementary", "supportive-care", "evidence:strong", "hair-loss" ;
  onco:related <https://onco.cc/ideas/idea-moon-hair-preservation-for-all/> ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/breast-cancer/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/chemotherapy/>, <https://onco.cc/fronts/devices/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/frozen-gloves-compression-taxane/>, <https://onco.cc/technologies/oral-cryotherapy-mucositis/>, <https://onco.cc/technologies/minoxidil-chemotherapy-alopecia/>, <https://onco.cc/technologies/wigs-cranial-prosthesis/> ;
  onco:drugs <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/docetaxel/>, <https://onco.cc/drugs/cabazitaxel/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/cyclophosphamide/> ;
  onco:companies <https://onco.cc/companies/paxman/>, <https://onco.cc/companies/dignitana/> ;
  onco:trials <https://onco.cc/trials/nct03711877/>, <https://onco.cc/trials/nct04986579/>, <https://onco.cc/trials/nct00515762/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-toxicity-qol/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-scalp-trial-jama-2017/> .